tiprankstipranks
Trending News
More News >
Rayonier Advanced Materials (RYAM)
NYSE:RYAM
Advertisement

Rayonier Advanced Materials (RYAM) AI Stock Analysis

Compare
226 Followers

Top Page

RYAM

Rayonier Advanced Materials

(NYSE:RYAM)

Rating:55Neutral
Price Target:
$4.50
▲(11.66%Upside)
Rayonier Advanced Materials' overall score of 55 reflects mixed financial performance and neutral technicals. Key challenges include profitability and valuation concerns due to ongoing net losses and negative P/E ratio. Despite liquidity strengths, reduced guidance and operational setbacks weigh significantly on the stock's outlook.

Rayonier Advanced Materials (RYAM) vs. SPDR S&P 500 ETF (SPY)

Rayonier Advanced Materials Business Overview & Revenue Model

Company DescriptionRayonier Advanced Materials Inc. manufactures and sells cellulose specialty products in the United States, China, Canada, Japan, Europe, Latin America, other Asian countries, and internationally. The company operates through High Purity Cellulose, Paperboard, and High-Yield Pulp segments. Its products include cellulose specialties, which are natural polymers that are used as raw materials to manufacture a range of consumer-oriented products, such as liquid crystal displays, impact-resistant plastics, thickeners for food products, pharmaceuticals, cosmetics, cigarette filters, high-tenacity rayon yarn for tires and industrial hoses, food casings, paints, and lacquers. The company also offers commodity products, such as commodity viscose pulp used in woven applications, including rayon textiles for clothing and other fabrics, as well as in non-woven applications comprising baby wipes, cosmetic and personal wipes, industrial wipes, and mattress ticking; and absorbent materials consisting of fluff fibers that are used as an absorbent medium in disposable baby diapers, feminine hygiene products, incontinence pads, convalescent bed pads, industrial towels and wipes, and non-woven fabrics. In addition, it provides paperboards for packaging, printing documents, brochures, promotional materials, paperback books or catalog covers, file folders, tags, and tickets; and high-yield pulps to produce paperboard and packaging products, printing and writing papers, and various other paper products. The company was founded in 1926 and is headquartered in Jacksonville, Florida.
How the Company Makes MoneyRayonier Advanced Materials primarily generates revenue by manufacturing and selling high-purity cellulose products to industries that require specialized materials. The company's cellulose specialties segment is its main revenue driver, as it supplies custom solutions to a diverse customer base across multiple industries. Additionally, RYAM engages in partnerships and long-term supply agreements with major corporations in sectors such as electronics, pharmaceuticals, and textiles, which provide stable and recurring revenue streams. The company's ability to innovate and develop new applications for its cellulose products further contributes to its earnings. Global demand for sustainable and high-performance materials also plays a significant role in driving the company's financial performance.

Rayonier Advanced Materials Earnings Call Summary

Earnings Call Date:May 06, 2025
(Q1-2025)
|
% Change Since: -4.50%|
Next Earnings Date:Aug 05, 2025
Earnings Call Sentiment Negative
The earnings call highlighted a strong liquidity position and debt reduction efforts. However, these positives were overshadowed by significant challenges including revenue and EBITDA declines, impacts from tariffs, operational setbacks, and increased input costs. The lowered financial guidance further indicates a challenging outlook.
Q1-2025 Updates
Positive Updates
Solid Liquidity Position
RYAM reported a liquidity of $272 million, with $130 million in cash, $131 million available under the ABL facility, and $11 million under the French factoring facility.
Debt Reduction Achievements
Net secured debt was reduced to $624 million, resulting in a net secured leverage ratio of 2.9 times covenant EBITDA.
Biomaterials Segment Stability
The Biomaterials segment maintained steady net sales of $7 million, with operating income flat at $2 million and EBITDA margins holding steady at 29%.
Negative Updates
Revenue and EBITDA Decline
RYAM reported an 8% decline in revenue and a 67% reduction in adjusted EBITDA compared to the first quarter of 2024.
Impact of Tariffs and Market Dynamics
Significant near-term issues include 125% tariffs imposed by China on U.S.-sourced cellulose commodities, affecting approximately $85 million of annual revenue.
Operational and Environmental Challenges
Operational setbacks from equipment failures and poor weather, higher energy prices, and increased remediation reserves for legacy sites were noted.
Foreign Exchange and Input Cost Increases
The company experienced an unfavorable $5 million change in foreign exchange and higher input costs, notably in energy, impacting results.
Lowered Financial Guidance
The full-year guidance for adjusted EBITDA was lowered to a range of $175 million to $185 million, with adjusted free cash flow between $5 million and $15 million.
Company Guidance
During the RYAM First Quarter 2025 Earnings Conference Call, the company provided a revised guidance for the full year, highlighting several key metrics and challenges. RYAM reported an 8% decline in revenue and a 67% reduction in adjusted EBITDA compared to the first quarter of 2024. As a result of compounding challenges, including tariffs, operational setbacks, and higher energy costs, the company lowered its full-year guidance for adjusted EBITDA to a range of $175 million to $185 million and adjusted free cash flow to between $5 million and $15 million. Despite these challenges, RYAM's financial foundation remains solid, with liquidity of $272 million, a net secured debt reduction to $624 million, and a net secured leverage ratio of 2.9 times covenant EBITDA. The company is actively mitigating the impact of 125% tariffs imposed by China on U.S. sourced cellulose commodities, which affect approximately $85 million of annual revenue, through customer advocacy, market diversification, and operational adjustments.

Rayonier Advanced Materials Financial Statement Overview

Summary
Rayonier Advanced Materials exhibits mixed financial performance with operational improvements and better cash flow management. However, challenges in profitability and equity position persist. Debt reduction and enhanced cash flow metrics are positive, but consistent revenue growth and profitability are needed.
Income Statement
55
Neutral
Rayonier Advanced Materials has shown inconsistent revenue growth with a declining trend from 2020 to 2025. The gross profit margin has been volatile, with a recent improvement in TTM (Trailing-Twelve-Months) compared to the previous year. However, the company continues to face challenges in achieving profitability, as evidenced by persistent net losses and negative net profit margins. The EBIT and EBITDA margins have seen some recovery in the TTM period, indicating potential operational improvements.
Balance Sheet
60
Neutral
The company's balance sheet reflects a moderate debt-to-equity ratio, with a significant reduction in total debt in the TTM period. Stockholders' equity has decreased over time, impacting the equity ratio. The return on equity remains negative due to ongoing net losses, posing a risk to financial stability. However, the reduction in debt levels suggests improved financial management.
Cash Flow
70
Positive
Rayonier Advanced Materials has demonstrated strong operating cash flow, with a notable increase in the TTM period. Free cash flow has also improved significantly, driven by reduced capital expenditures. The operating cash flow to net income ratio is robust, indicating efficient cash generation relative to net income. The company has managed to enhance its free cash flow position, which is a positive indicator for liquidity and future investments.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.63B1.64B1.72B1.41B1.74B
Gross Profit165.58M88.15M123.00M75.00M138.00M
EBITDA173.69M81.32M172.33M121.82M92.99M
Net Income-39.00M-101.83M-25.00M-48.00M1.00M
Balance Sheet
Total Assets2.13B2.18B2.35B2.44B2.53B
Cash, Cash Equivalents and Short-Term Investments125.22M75.77M152.00M253.00M94.00M
Total Debt729.82M796.62M853.00M929.00M1.08B
Total Liabilities1.41B1.44B1.52B1.63B1.83B
Stockholders Equity713.88M746.45M829.00M814.00M695.00M
Cash Flow
Free Cash Flow95.67M8.60M-69.00M137.00M47.00M
Operating Cash Flow203.61M136.27M69.00M232.00M124.00M
Investing Cash Flow-108.00M-127.28M-94.00M86.00M-78.00M
Financing Cash Flow-42.48M-86.95M-73.00M-156.00M-19.00M

Rayonier Advanced Materials Technical Analysis

Technical Analysis Sentiment
Negative
Last Price4.03
Price Trends
50DMA
4.04
Negative
100DMA
4.45
Negative
200DMA
6.26
Negative
Market Momentum
MACD
0.05
Positive
RSI
44.63
Neutral
STOCH
25.87
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RYAM, the sentiment is Negative. The current price of 4.03 is below the 20-day moving average (MA) of 4.22, below the 50-day MA of 4.04, and below the 200-day MA of 6.26, indicating a bearish trend. The MACD of 0.05 indicates Positive momentum. The RSI at 44.63 is Neutral, neither overbought nor oversold. The STOCH value of 25.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RYAM.

Rayonier Advanced Materials Risk Analysis

Rayonier Advanced Materials disclosed 29 risk factors in its most recent earnings report. Rayonier Advanced Materials reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Rayonier Advanced Materials Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
$572.99M6.8511.26%3.01%6.03%5079.05%
62
Neutral
$10.39B9.841.51%2.86%2.35%-34.25%
56
Neutral
$621.03M-5.28%-4.23%-259.01%
55
Neutral
$277.78M-10.12%2.20%34.71%
55
Neutral
$909.57M-8.44%9.06%4.15%57.25%
54
Neutral
$183.97M11.43-3.29%5.71%-33.92%-58.53%
47
Neutral
$109.47M-26.63%-11.91%-26768.00%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RYAM
Rayonier Advanced Materials
4.03
-2.62
-39.40%
FF
Futurefuel
4.16
-1.15
-21.66%
LXU
Lsb Industries
8.71
-0.40
-4.39%
TROX
TRONOX
5.52
-9.72
-63.78%
ASIX
AdvanSix
21.24
-6.08
-22.25%
ORGN
Origin Materials
0.78
-0.12
-13.33%

Rayonier Advanced Materials Corporate Events

Executive/Board ChangesShareholder Meetings
Rayonier Advanced Materials Holds Annual Stockholders Meeting
Neutral
May 16, 2025

On May 14, 2025, Rayonier Advanced Materials held its Annual Meeting of Stockholders, where key decisions were made regarding the company’s governance and executive compensation. Stockholders elected three directors to serve until 2028, approved executive compensation and the 2023 Incentive Stock Plan, and ratified Grant Thornton LLP as the accounting firm for 2025, while proposals to declassify the board and eliminate supermajority voting provisions were not approved.

The most recent analyst rating on (RYAM) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Rayonier Advanced Materials stock, see the RYAM Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 29, 2025